GENEVA, Dec. 8 -- EHRLICH BIOTECHNOLOGY CO., LTD. (Room 203, Building 21, Hexiang Technology Centre, Qiantang New DistrictHangzhou, Zhejiang 310020), 爱尔利希生物科技有限公司 (中国浙江省杭州市钱塘新区和享科技中心21幢203室) filed a patent application (PCT/CN2025/097724) for "ANTI-EGFR ANTIBODY DRUG CONJUGATE AND USE THEREOF" on May 28, 2025. With publication no. WO/2025/247261, the details related to the patent application was published on Dec 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) sy...